Sunday, February 26, 2023 10:37:19 AM
After the POP from BLCO's new CEO we went down to around 8.60 the day before ER and hit 10.23 before the first half hour of trading. (Almost 20% gain) Closed Friday (2/24) @ 9.57 The 500 DMA crossed over the 200 DMA but the 200 was desending so not sure if that's a golden cross or not. However BHC hit 7.10 around 2/12 or 2/13 which is almost a 45% gain. This could go either way and try to run 75% around 12.5 which would be more than 200% from it's 52 week low of 4. With Almost 71% held by instituitions according to TDA and less than 7% short interest. The chart also shows a gap between 7.50 and 8 so that could fill too. That BLCO (18.33 currently) distribution makes me think, (9.18 for 50.1% & 14.66 for 80%) and we're trading like 50.1% is possible (BLCO short interest 15.5% and 12.6% inst. owned) and after that we'd fill that gap and maybe make a new low but might hold 4 in anticipation of getting 29.9% more in a much later time as the company uses the other 8.7% of BLCO shares to pay down debt... Will plan to trade accordingly while keeping a core for an unexpected event. Basically 'flip for freebies'
Good luck
Recent BHC News
- Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China • PR Newswire (US) • 05/28/2026 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:05:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:02:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:00:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:57:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:30:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:25:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:19:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:14:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:10:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 09:41:33 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 09:16:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 08:18:10 PM
- Bausch Health Announces 2026 Annual Meeting of Shareholder Results • PR Newswire (US) • 05/19/2026 08:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 01:42:39 PM
- Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference • PR Newswire (Canada) • 05/13/2026 11:00:00 AM
- Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference • PR Newswire (US) • 05/13/2026 11:00:00 AM
- Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference • PR Newswire (Canada) • 05/12/2026 08:15:00 PM
- Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference • PR Newswire (US) • 05/12/2026 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 08:10:14 PM
- BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS • PR Newswire (Canada) • 04/29/2026 08:05:00 PM
- BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS • PR Newswire (US) • 04/29/2026 08:05:00 PM
- Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering • PR Newswire (US) • 04/14/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/08/2026 08:07:14 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/08/2026 08:06:22 PM
